What does jornay PM — product revenues, net mean?

This metric represents the total net revenue generated from the sale of a specific pharmaceutical product after accounting for returns, allowances, and rebates. It serves as a primary indicator of the product's market adoption and commercial success within the company's portfolio.

Collegium Pharmaceutical, Inc. COLL Jornay PM — Product revenues, net

Other product segments

Belbuca

$52.65M+1.9%

Xtampza ER

$50.77M—

Nucynta IR

$26.08M-4.9%

Nucynta ER

$18.23M-7.4%

Symproic and other

$14.45M—

Symproic

$4.19M+49.0%

Nucynta ER AG

$1.45M—

Nucynta IR AG

$1.26M—

Similar metrics at other companies

XER

XERSProduct revenue, net — Product revenue, net

$82.45M+42.6%

ARDXProduct sales, net — Total revenues

$93.37M+37.7%

GERNProduct revenue, net — Total revenues

$51.77M+31.3%

ESPRProduct sales, net — Total Revenues

$43.4M+24.3%

VRTXProduct revenues, net — Product revenues, net

$2.99B+8.2%

RYTMProduct revenue, net — Total revenues

$60.11M+59.4%

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+20.4%

Enterprise value$869.67M+2.5%

P/E15.4×-6.4×

P/S1.5×0.0×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s jornay pm — product revenues, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s jornay PM — product revenues, net?: Collegium Pharmaceutical, Inc. (COLL) reported jornay PM — product revenues, net of $38.89M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s jornay PM — product revenues, net changed year-over-year?: Collegium Pharmaceutical, Inc.'s jornay PM — product revenues, net increased by 36.3% year-over-year, from $28.54M to $38.89M.
What does jornay PM — product revenues, net mean?: This metric represents the total net revenue generated from the sale of a specific pharmaceutical product after accounting for returns, allowances, and rebates. It serves as a primary indicator of the product's market adoption and commercial success within the company's portfolio.